Headline;Month;Day
The Pfizer Mansion in Clinton Hill;6;8
Emergency Rooms Run Out of Vital Drugs, and Patients Are Feeling It;7;1
Consumers Struggle to Find EpiPens;5;10
How Pfizer Developed a Drug;3;8
Infant Deaths Fall Sharply in Africa With Routine Antibiotics;4;25
Today's Business With Duff Wilson;8;28
Back Story With The Times's Gardiner Harris;8;28
Review: Fighting to Save Her ‘Little Pink House’;4;19
F.D.A. Approves Generic EpiPen That May Be Cheaper;8;16
Clinton Hill Mansion With a Rock ’n’ Roll History;6;8
Merck Is Lowering Drug Prices. There’s a Catch.;7;19
Maxine Ames, Alan Gandler;11;4
Caroline Katzman, Alec Guzov;8;12
Made in China: New and Potentially Lifesaving Drugs;1;3
Stephanie Friedman, Stanley Gartshein;9;30
Stephanie Tsay, Benjamin Levick;9;23
Molly Cordell, James Wartski;12;30
Regan Marin, Huan Nguyen;8;5
How the Trump Administration Is Browbeating Big Pharma on Drug Prices;7;23
Sanofi, Facing Threat From Generics, Moves to Buy Hemophilia Drug Maker;1;22
DealBook Briefing: China Has to Think Beyond the Tariff Two-Step;7;11
Massachusetts, a Health Pioneer, Turns Its Focus to Drug Prices. It’s in for a Fight.;3;31
Which Drug for Erectile Dysfunction Is Better: Viagra or Cialis?;9;7
M.L.B. Asks Senator Cindy Hyde-Smith to Return $5,000 Donation;11;25
DealBook Briefing: Inside Facebook’s Huge Data Giveaway to Its Big Tech Brethren;12;19
The Price They Pay ;3;5
Drug Maker Pays $360 Million to Settle Investigation Into Charity Kickbacks;12;6
Investors Betting Against Tesla Made $1 Billion on Friday;8;18
Companies Asked a Mississippi Senator to Refund Donations. They Are Still Waiting.;12;14
Clueless Versus Trump;1;20
F.D.A. Names and Shames Drug Makers to Encourage Generic Competition;5;17
How C.E.O.s Should Spend Their Tax Cuts;2;9
Death Penalty Madness in Alabama;2;27
Herbert Kaiser, 94, Health Care Champion in South Africa, Dies;4;4
DealBook Briefing: Google’s E.U. Fine Might Not Matter;7;19
DealBook Briefing: The New Scotus Pick Could Be a Boon for Business;7;10
Companies Warn of Hits From Tax Cuts. Don’t Be Fooled.;1;4
K2 Eyed as Culprit After 14 People Overdose in Brooklyn;5;20
Spreadsheets at Dawn: The New Tax Battle Is All About Data;2;28
Syria, Fed Rates, Galápagos Islands: Your Thursday Briefing;12;19
Requiring Prices in Drug Ads: Would It Do Any Good? Is It Even Legal?;5;19
New Jersey Sues Pharmaceutical Company Amid Spiraling Opioid Crisis;11;13
In 2018, Did Business Get Too Big?;12;21
The Market’s Trump Test Is About to Get Real: DealBook Briefing;5;8
With Augmented and Virtual Reality, Tour Your Office Before It’s Built;12;4
With $240 Million Deal, Floodgates Open for Air Rights in Midtown East;3;2
Two Prostate Cancer Drugs Delay Spread of the Disease by Two Years;2;8
For Scientists Racing to Cure Alzheimer’s, the Math Is Getting Ugly;7;23
What’s Behind a Pitch for the Little-Guy Investor? Big Money Interests;7;24
What’s Next for Stocks After the China Tariffs: DealBook Briefing;3;22
DealBook Briefing: How Goldman Quieted a Whistle-Blower;9;12
DealBook Briefing: Big Tech May Need to Swallow Its Political Pride;9;4
DealBook Briefing: Google’s Mea Culpa and Future Murdoch Deals;11;2
A New Way to Detect Breast Cancer;8;28
Angry About Tariffs and Insults, Canadians Vow to Boycott U.S. Goods and Travel;7;11
As Trump Prepares Plan to Lower Drug Prices, Big Pharma Girds for a Fight;5;6
They Thought Hemophilia Was a ‘Lifelong Thing.’ They May Be Wrong.;8;13
How Skadden, the Giant Law Firm, Got Entangled in the Mueller Investigation;2;24
The True Source of the N.R.A.’s Clout: Mobilization, Not Donations;2;24
The Brooklyn Army Terminal: New York’s Next Manufacturing Hub?;11;23
What Amazon Could Learn From Google in New York City;12;14
DealBook Briefing: How Not to Increase Board Diversity;10;2
Is Capital or Labor Winning at Your Favorite Company? Introducing the Marx Ratio;5;21
As Trade Tensions Rise, Here Are Some Lessons From Brexit: DealBook Briefing;4;4
China’s Health Care Crisis: Lines Before Dawn, Violence and ‘No Trust’;9;30
Many People Taking Antidepressants Discover They Cannot Quit;4;7
DealBook Briefing: How Monday’s Stock Plunge Ranks?;2;5
This Week’s Wedding Announcements;12;30
Dropbox’s First-Day Pop Should Give Investors Pause: DealBook Briefing;3;23
This Week’s Wedding Announcements;8;12
This Week’s Wedding Announcements;8;3
The Highest-Paid C.E.O.s in 2017;5;25
This Week’s Wedding Announcements;9;30
This Week’s Wedding Announcements;11;4
This Week’s Wedding Announcements;9;23
Corrections: April 12, 2018;4;12
